The great promise of liquid biopsy technology is in early cancer detection. That is, it's the great future promise. Right? This past month at the annual cancer conference, ASCO, we heard about one such flagship company announcing just which technology they were going to use to do it--DNA methylation.
Share this post

Early Cancer Detection: Is This Company Ahead of Grail?
www.mendelspod.com
Early Cancer Detection: Is This Company Ahead of Grail?
Jul 9, 2019
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
Listen on
Substack App
Apple Podcasts
RSS Feed
Early Cancer Detection: Is This Company Ahead of Grail?